DEPT OF DEFENSE
- Posted
- Sep 30, 2021
- Due
- Not specified
- Place of performance
- Place of performance not specified
- NAICS
- 325412
Award NoticeAwarded
Levalbuterol HCL Solution
DEPT OF DEFENSE · DLA TROOP SUPPORT
This notice records an award. Find active opportunities
Award Information
DEPT OF DEFENSE awarded this contract to Teva Pharmaceuticals USA, Inc. for $5,687,207 on August 31, 2022, as part of federal procurement initiatives.
This award is part of federal acquisition procurement activities.
- Award Number
- SPE2D222D0146
- Award Amount
- $5,687,207
- Award Date
- August 31, 2022
- Awardee
- Teva Pharmaceuticals USA, Inc.
Contract Details
- Solicitation number
- SPE2D221R0116
- Notice ID
- sam-opportunity-489e79fbc6244b508a5d07f5e4d8e81b
- Opportunity Type
- Award Notice
- Agency
- DEPT OF DEFENSE
- Sub-Agency
- DEFENSE LOGISTICS AGENCY
- Office
- DLA TROOP SUPPORT
- Posted Date
- Wednesday, August 23, 2023
- Response Deadline
- Not specified
- PSC Code
- 6505
- Set-Aside
- Full & Open Competition
- Place of Performance
- Cheshire, GB-ENG, GBR
- Status
- Awarded
Description
P00003 SPE2D222D0146 Modification to incorporate Drug Supply Chain Security Act language into solication for subject contract. P00002 SPE2D222D0146 Modification to Invoke Option Year 1. P00001 SPE2D222D0146 Modification to incorporate clause FAR 52.204-27 Prohibituion on a ByteDance Covered Application (June 2023) Contract Award for Leavalbuterol HCL Solution SPE2D222D0146
Documents and contact
Check the official notice for attachments and access requirements ↗
- Contact
- Phyllis Daraio
- Phyllis.Daraio@dla.mil
- Phone
- 2157377941
Loadingchange history…
Loadingrelated notices…